Cytotoxicity (as of %Control) IC₅₀ value (mean ±SD in µM) of the tested compounds vs. Positive controls Cisplatin and doxorubicin against gastrointestinal and colorectal... by MohammedBashar Al-Qazzan (22439236)

Subjects:

Estimated prevalence (A), DALYs (B), and mortality (C) rates for IBD among WCBA by 2040. by Jiefeng Zhao (9090305)

Subjects:

Median EQ-5D-3L index values during 5 years of follow-up. by Karl Ingard (22582091)

Subjects:

Subgroup Analysis of the Occurrence of Secondary Endpoints. by Karl Ingard (22582091)

Subjects:

Study flow chart. by Karl Ingard (22582091)

Subjects:

Kaplan-Meier curve of the primary outcome. by Karl Ingard (22582091)

Subjects:

Number of Patients Who Reached the Primary and Secondary Endpoints During Follow-up. by Karl Ingard (22582091)

Subjects:

Subgroup Analysis of the Occurrence of the Primary Endpoint and Its Components. by Karl Ingard (22582091)

Subjects:

Comparing detector performance against increasing signal to noise ratios. by Bernd Porr (32394)

Effects of clonal integration and <i>Bacillus subtilis</i> on total mass (A, E, I), leaf biomass (B, F, J), stolon biomass (C, G, K), and root biomass (D, H, L) of the basal, apica... by Bing-Nan Zhao (21553401)

Subjects:

Distribution of responses to vital signs. by Lisa Thiele (6468056)

Subjects:

Survey tool development process. by Lisa Thiele (6468056)

Subjects:

Respondent characteristics. by Lisa Thiele (6468056)

Subjects:

Local consumer escalation process (adapted from Local Health Network (CALHN) procedure 2019) [16]. by Lisa Thiele (6468056)

Subjects:

Data Set. by Yang Li (7082)

Subjects:

Test oil circuit circulation diagram. by Yang Li (7082)

Subjects:

Experiment Schedule. by Yang Li (7082)

Subjects:

SEM image of 10-micron iron oxide particles. by Yang Li (7082)

Subjects:

Particle size distribution of iron oxide. by Yang Li (7082)

Subjects:

Relevant parameters of test piece. by Yang Li (7082)

Subjects: